{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T06:47:21Z","timestamp":1778050041731,"version":"3.51.4"},"reference-count":63,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jogc.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology Canada"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.jogc.2017.11.007","type":"journal-article","created":{"date-parts":[[2017,12,20]],"date-time":"2017-12-20T05:35:01Z","timestamp":1513748101000},"page":"e1-e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["No. 133-Prevention of Rh Alloimmunization"],"prefix":"10.1016","volume":"40","author":[{"given":"Karen Fung Kee","family":"Fung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Eason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogc.2017.11.007_bib0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1471-0528.1998.tb10286.x","article-title":"The scientific basis of antenatal prophylaxis","volume":"Suppl 18","author":"Urbaniak","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.jogc.2017.11.007_bib0015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2105\/AJPH.88.2.209","article-title":"The decline of Rh hemolytic disease: should Rh prophylaxis get all the credit?","volume":"88","author":"Joseph","year":"1998","journal-title":"Am J Public Health"},{"key":"10.1016\/j.jogc.2017.11.007_bib0020","first-page":"627","article-title":"Antenatal prophylaxis of Rh isoimmunization: 28 weeks gestation service programme","volume":"118","author":"Bowman","year":"1978","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.jogc.2017.11.007_bib0025","series-title":"The Rh program of Nova Scotia 1964\u20131994","author":"Armson","year":"1995"},{"key":"10.1016\/j.jogc.2017.11.007_bib0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0887-7963(87)70010-8","article-title":"Failures of intravenous Rh immune globulin prophylaxis: an analysis for the reasons of such failures","volume":"I","author":"Bowman","year":"1987","journal-title":"Transf Med Rev"},{"key":"10.1016\/j.jogc.2017.11.007_bib0035","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0140-6736(83)90232-5","article-title":"The Yorkshire antenatal anti-D immunoglobulin trial in primigravidae","volume":"2","author":"Tovey","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.jogc.2017.11.007_bib0040","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1537-2995.1998.38198141506.x","article-title":"Consensus conference on anti-D prophylaxis, April 7 & 8, 1997: final consensus statement of the Royal College of Edinburgh\/Royal College of Obstetricians and Gynaecologists","volume":"38","author":"Urbaniak","year":"1998","journal-title":"Transfusion"},{"key":"10.1016\/j.jogc.2017.11.007_bib0045","series-title":"Canadian task force on the periodic health exam","first-page":"xxxvii","author":"Woolf","year":"1994"},{"issue":"2","key":"10.1016\/j.jogc.2017.11.007_bib0050","article-title":"Anti-D administration after childbirth for preventing Rhesus alloimmunization","author":"Crowther","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogc.2017.11.007_bib0055","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4049\/jimmunol.87.2.189","article-title":"Experimental iso-immunization to hemo-antigens in man","author":"Stern","year":"1961","journal-title":"J Immunol"},{"key":"10.1016\/j.jogc.2017.11.007_bib0060","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/ajcp\/110.3.281","article-title":"Use of Rh immune globulin. ASCP Practice Parameter","volume":"110","author":"Hartwell","year":"1998","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jogc.2017.11.007_bib0065","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/00016348909087688","article-title":"Prenatal Rh-immune globulin prophylaxis with 300 meg immune globulin anti-D in the 28th week of pregnancy","volume":"68","author":"Trolle","year":"1989","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jogc.2017.11.007_bib0070","doi-asserted-by":"crossref","first-page":"F60","DOI":"10.1136\/fn.84.1.F60","article-title":"Maternal anti-D prophylaxis during pregnancy does not cause neonatal haemolysis","volume":"84","author":"Maayan-Metzger","year":"2001","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.jogc.2017.11.007_bib0075","first-page":"9","article-title":"Safety profile of WINHRO Anti-D","volume":"35","author":"Hong","year":"1998","journal-title":"Sem Hematol"},{"key":"10.1016\/j.jogc.2017.11.007_bib0080","series-title":"Compendium of pharmaceuticals and specialties (CPS)","first-page":"1714","article-title":"WinRho SDF\u2122 Rh (D) immune globulin (human) passive immunizing agent","author":"Canadian PharmacistsAssociation","year":"2001"},{"key":"10.1016\/j.jogc.2017.11.007_bib0085","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1136\/bmj.308.6929.613a","article-title":"Irish mothers called for hepatitis C virus screening","volume":"308","author":"Murdoch","year":"1994","journal-title":"Br J Med"},{"key":"10.1016\/j.jogc.2017.11.007_bib0090","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0140-6736(94)90679-3","article-title":"Hepatitis C viraemia in recipients of Irish intravenous anti-D immunoglobulin","volume":"344","author":"Power","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jogc.2017.11.007_bib0095","first-page":"623","article-title":"Rh isoimmunization during pregnancy: antenatal prophylaxis","volume":"118","author":"Bowman","year":"1978","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.jogc.2017.11.007_bib0100","first-page":"24","article-title":"Preventing Rh sensitization during pregnancy","volume":"2","author":"Bowman","year":"1978","journal-title":"Perinat Care"},{"key":"10.1016\/j.jogc.2017.11.007_bib0105","first-page":"349","article-title":"Effect on primary Rh immunization of delayed administration anti-Rh","volume":"28","author":"Samson","year":"1975","journal-title":"Immunology"},{"key":"10.1016\/j.jogc.2017.11.007_bib0110","first-page":"238","article-title":"Prevention of sensitization to Rh with anti-Rh gamma globulin","volume":"23","author":"Gorman","year":"1964","journal-title":"Fred Proc"},{"key":"10.1016\/j.jogc.2017.11.007_bib0115","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/00003081-199106000-00010","article-title":"Antenatal suppression of Rh alloimmunization","volume":"34","author":"Bowman","year":"1991","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.11.007_bib0120","first-page":"749","article-title":"Transplacental fetal haemorrhage after amniocentesis","volume":"66","author":"Bowman","year":"1985","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.11.007_bib0125","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1046\/j.1537-2995.1990.30490273444.x","article-title":"Fetomaternal hemorrhage: incidence, risk factors, time of occurrence and clinical effects","volume":"30","author":"Sebring","year":"1990","journal-title":"Transfusion"},{"key":"10.1016\/j.jogc.2017.11.007_bib0130","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0002-9378(87)90228-6","article-title":"Clinical high-risk designation does not predict excess fetal-maternal hemorrhage","volume":"156","author":"Ness","year":"1987","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.11.007_bib0135","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/0002-9378(86)90725-8","article-title":"Use of the erythrocyte rosette test to screen for excessive fetomaternal hemorrhage in Rh negative women","volume":"154","author":"Stedman","year":"1986","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.11.007_bib0140","first-page":"1245","article-title":"The pathogenesis and prevention of Rh immunization","volume":"97","author":"Zipursky","year":"1967","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.jogc.2017.11.007_bib0145","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/00003081-197709000-00021","article-title":"Rh hemolytic disease of the newborn -the disease eradicated by immunology","volume":"20","author":"Zipursky","year":"1977","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.11.007_bib0150","series-title":"Haemolytic disease of the fetus and newborn due to anti-Rh D (Rh D haemolytic disease)","first-page":"546","year":"1993"},{"key":"10.1016\/j.jogc.2017.11.007_bib0155","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0887-7963(88)70039-5","article-title":"The prevention of Rh immunization","volume":"2","author":"Bowman","year":"1988","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.jogc.2017.11.007_bib0160","series-title":"Isoimmunization in pregnancy","first-page":"899","author":"Jackson","year":"1996"},{"key":"10.1016\/j.jogc.2017.11.007_bib0165","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/0002-9378(90)91083-O","article-title":"The incidence of significant fetomaternal haemorrhage in patients undergoing cesarean section","volume":"163","author":"Feldman","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.11.007_bib0170","series-title":"ACOG Practice Bulletin","article-title":"Prevention of Rh D isoimmunization","author":"American College of Obstetricians and Gynecologists","year":"1999"},{"key":"10.1016\/j.jogc.2017.11.007_bib0175","series-title":"Bulletin #98-2","first-page":"1","article-title":"Prevention of hemolytic disease of the newborn due to anti-D","author":"Snyder","year":"1998"},{"key":"10.1016\/j.jogc.2017.11.007_bib0180","series-title":"Technical manual","first-page":"12","author":"Vengelen-TylerV","year":"1996"},{"key":"10.1016\/j.jogc.2017.11.007_bib0185","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0950-3536(05)80153-2","article-title":"The role of Rh antibodies in haemolytic disease of the newborn","volume":"6","author":"Hadley","year":"1993","journal-title":"Baillieres Clin Haematol"},{"key":"10.1016\/j.jogc.2017.11.007_bib0190","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1471-0528.1998.tb10039.x","article-title":"Anti-D immunoglobulin in RhD prophylaxis","volume":"105","author":"Robson","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.jogc.2017.11.007_bib0195","series-title":"Screening for D (Rh) sensitization in pregnancy","first-page":"116","author":"Beaulieu","year":"1994"},{"key":"10.1016\/j.jogc.2017.11.007_bib0200","series-title":"Guide to Clinical Preventive Services","article-title":"Screening for D (Rh) incompatibility. US Preventive Services Task Force","author":"Diguiseppe","year":"1996"},{"key":"10.1016\/j.jogc.2017.11.007_bib0205","series-title":"Anti-D administration in pregnancy for preventing Rhesus alloimmunization","author":"Crowther","year":"2001"},{"key":"10.1016\/j.jogc.2017.11.007_bib0210","first-page":"101","article-title":"The antepartum use of anti-D immunoglobulin in rhesus negative women. Parallel evaluation of a multicentre study carried out in the region of Paris","volume":"16","author":"Hutchet","year":"1987","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1016\/j.jogc.2017.11.007_bib0215","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00003081-198206000-00012","article-title":"Irregular antibodies causing hemolytic disease of the newborn: a continuing problem","volume":"25","author":"Weinstein","year":"1982","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.11.007_bib0220","series-title":"Hemolytic disease (erythroblastosis fetalis)","first-page":"736","author":"Bowman","year":"1999"},{"key":"10.1016\/j.jogc.2017.11.007_bib0225","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0002-9378(88)80100-5","article-title":"The cost of irregular antibody screening","volume":"159","author":"Barss","year":"1988","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.11.007_bib0230","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1365-3148.1996.d01-518.x","article-title":"Guidelines for blood grouping and red cell antibody testing during pregnancy","volume":"6","author":"Mitchell","year":"1996","journal-title":"Transfus Med"},{"key":"10.1016\/j.jogc.2017.11.007_bib0235","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2257.1991.tb00278.x","article-title":"\u201cPartial D\u201d women with anti-D alloimmunization in pregnancy","volume":"13","author":"Mayne","year":"1991","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.jogc.2017.11.007_bib0240","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1046\/j.1537-2995.1982.22182154227.x","article-title":"Rh immune globulin and the Rh-positive, D\u201d variant mother","volume":"22","author":"Konugres","year":"1982","journal-title":"Transfusion"},{"key":"10.1016\/j.jogc.2017.11.007_bib0245","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.5858\/2000-124-1118-PAPRTW","article-title":"Policies and procedures related to weak D phenotype testing and Rh immune globulin administration. Results from supplementary questions to the Comprehensive Transfusion Medicine Survey of the College of American Pathologists","volume":"124","author":"Domen","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jogc.2017.11.007_bib0250","series-title":"New applications of Rh immune globulin: effect on protocols","first-page":"199","author":"Gorman","year":"1981"},{"key":"10.1016\/j.jogc.2017.11.007_bib0255","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0002-9378(16)34502-1","article-title":"Demonstration of Rh antigens in a 38-day-old fetus","volume":"99","author":"Bergstrom","year":"1967","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.11.007_bib0260","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1001\/jama.1970.03180030049009","article-title":"Fetal erythrocytes in maternal circulation after spontaneous abortion","volume":"214","author":"Litwak","year":"1970","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.jogc.2017.11.007_bib0265","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1479-828X.1995.tb02147.x","article-title":"Anti-D administration in early pregnancy: time for a new protocol","volume":"35","author":"De Crespigny","year":"1995","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.jogc.2017.11.007_bib0270","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00006250-199203000-00011","article-title":"Fetomaternal haemorrhage in threatened abortion","volume":"79","author":"Von Stein","year":"1992","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.11.007_bib0275","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/0002-9378(84)90405-8","article-title":"The expression of Rh-D factor in human trophoblast","volume":"150","author":"van'tVeer","year":"1984","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.11.007_bib0280","first-page":"1","article-title":"An assessment of the hazards of amniocentesis. Report to the Medical Research Council by their Working Party on Amniocentesis","volume":"85","year":"1978","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.jogc.2017.11.007_bib0285","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/oxfordjournals.humrep.a136340","article-title":"Fete-maternal transfusion after chorionic villus sampling: clinical implications","volume":"1","author":"Brambati","year":"1986","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jogc.2017.11.007_bib0290","first-page":"839","article-title":"Fetomaternal haemorrhage following funipuncture: increase in severity of maternal red-cell alloimmuni:z;ation","volume":"84","author":"Bowman","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.11.007_bib0295","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1471-0528.1975.tb00690.x","article-title":"Fetematernal hemorrhage following successful and unsuccessful attempts at external cephalic version","volume":"82","author":"Marcus","year":"1975","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.jogc.2017.11.007_bib0300","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/00016348909087690","article-title":"100 cases of external cephalic version with special reference to fetomaternal transfusion","volume":"68","author":"Nord","year":"1989","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jogc.2017.11.007_bib0305","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1479-828X.1995.tb01862.x","article-title":"Fetematernal hemorrhage after external cephalic version at term","volume":"35","author":"Lau","year":"1995","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.jogc.2017.11.007_bib0310","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJM199012063232307","article-title":"Blunt trauma during pregnancy","volume":"323","author":"Pearlman","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jogc.2017.11.007_bib0315","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1537-2995.1971.tb04425.x","article-title":"Studies on Rh prophylaxis: II","volume":"II","author":"Pollack","year":"1971","journal-title":"Transfusion"},{"key":"10.1016\/j.jogc.2017.11.007_bib0320","first-page":"1","article-title":"Manitoba guidelines for prenatal antibody screening: indications for administration of Rh immune globulin [newsletter]","volume":"35","author":"Manitoba Rh Program","year":"1999","journal-title":"Coli Physicians Surg Manitoba"}],"container-title":["Journal of Obstetrics and Gynaecology Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216317311118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216317311118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T16:50:26Z","timestamp":1728579026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1701216317311118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S1701216317311118"],"URL":"https:\/\/doi.org\/10.1016\/j.jogc.2017.11.007","relation":{},"ISSN":["1701-2163"],"issn-type":[{"value":"1701-2163","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"No. 133-Prevention of Rh Alloimmunization","name":"articletitle","label":"Article Title"},{"value":"Journal of Obstetrics and Gynaecology Canada","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogc.2017.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 Published by Elsevier Inc. on behalf of The Society of Obstetricians and Gynaecologists of Canada\/La Soci\u00e9t\u00e9 des obst\u00e9triciens et gyn\u00e9cologues du Canada","name":"copyright","label":"Copyright"}]}}